IBDEI1PV ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,27429,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27429,1,2,0)
;;=2^H0020
;;^UTILITY(U,$J,358.3,27429,1,3,0)
;;=3^Methadone Administration &/or Svc by Lincensed Program
;;^UTILITY(U,$J,358.3,27430,0)
;;=H0025^^112^1330^2^^^^1
;;^UTILITY(U,$J,358.3,27430,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27430,1,2,0)
;;=2^H0025
;;^UTILITY(U,$J,358.3,27430,1,3,0)
;;=3^Addictions Health Prevention/Education
;;^UTILITY(U,$J,358.3,27431,0)
;;=H0030^^112^1330^4^^^^1
;;^UTILITY(U,$J,358.3,27431,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27431,1,2,0)
;;=2^H0030
;;^UTILITY(U,$J,358.3,27431,1,3,0)
;;=3^Addictions Hotline Services
;;^UTILITY(U,$J,358.3,27432,0)
;;=T1016^^112^1331^1^^^^1
;;^UTILITY(U,$J,358.3,27432,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27432,1,2,0)
;;=2^T1016
;;^UTILITY(U,$J,358.3,27432,1,3,0)
;;=3^Case Management per 15min
;;^UTILITY(U,$J,358.3,27433,0)
;;=96372^^112^1332^1^^^^1
;;^UTILITY(U,$J,358.3,27433,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27433,1,2,0)
;;=2^96372
;;^UTILITY(U,$J,358.3,27433,1,3,0)
;;=3^Ther/Proph/Diag Inj SC/IM
;;^UTILITY(U,$J,358.3,27434,0)
;;=96374^^112^1332^2^^^^1
;;^UTILITY(U,$J,358.3,27434,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27434,1,2,0)
;;=2^96374
;;^UTILITY(U,$J,358.3,27434,1,3,0)
;;=3^Ther/Proph/Diag Inj IV Push
;;^UTILITY(U,$J,358.3,27435,0)
;;=96376^^112^1332^3^^^^1
;;^UTILITY(U,$J,358.3,27435,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27435,1,2,0)
;;=2^96376
;;^UTILITY(U,$J,358.3,27435,1,3,0)
;;=3^Tx/Pro/Dx Inj,ea addl sequential IVP of Same Drug-Add-on
;;^UTILITY(U,$J,358.3,27436,0)
;;=J2680^^112^1333^3^^^^1
;;^UTILITY(U,$J,358.3,27436,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27436,1,2,0)
;;=2^J2680
;;^UTILITY(U,$J,358.3,27436,1,3,0)
;;=3^Fluphenazine Decanoate up to 25mg
;;^UTILITY(U,$J,358.3,27437,0)
;;=J1631^^112^1333^4^^^^1
;;^UTILITY(U,$J,358.3,27437,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27437,1,2,0)
;;=2^J1631
;;^UTILITY(U,$J,358.3,27437,1,3,0)
;;=3^Haloperidol Decanoate per 50mg
;;^UTILITY(U,$J,358.3,27438,0)
;;=J2315^^112^1333^5^^^^1
;;^UTILITY(U,$J,358.3,27438,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27438,1,2,0)
;;=2^J2315
;;^UTILITY(U,$J,358.3,27438,1,3,0)
;;=3^Naltrexone,Depot Form 1mg
;;^UTILITY(U,$J,358.3,27439,0)
;;=J2426^^112^1333^7^^^^1
;;^UTILITY(U,$J,358.3,27439,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27439,1,2,0)
;;=2^J2426
;;^UTILITY(U,$J,358.3,27439,1,3,0)
;;=3^Paliperidone Palmitate Extend Release per 1mg
;;^UTILITY(U,$J,358.3,27440,0)
;;=J2794^^112^1333^8^^^^1
;;^UTILITY(U,$J,358.3,27440,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27440,1,2,0)
;;=2^J2794
;;^UTILITY(U,$J,358.3,27440,1,3,0)
;;=3^Risperidone Long Act per 0.5mg
;;^UTILITY(U,$J,358.3,27441,0)
;;=J2315^^112^1333^9^^^^1
;;^UTILITY(U,$J,358.3,27441,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27441,1,2,0)
;;=2^J2315
;;^UTILITY(U,$J,358.3,27441,1,3,0)
;;=3^Vivitrol 1mg
;;^UTILITY(U,$J,358.3,27442,0)
;;=J0401^^112^1333^1^^^^1
;;^UTILITY(U,$J,358.3,27442,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27442,1,2,0)
;;=2^J0401
;;^UTILITY(U,$J,358.3,27442,1,3,0)
;;=3^Aripiprazole Ext Rel 1mg
;;^UTILITY(U,$J,358.3,27443,0)
;;=J2358^^112^1333^6^^^^1
;;^UTILITY(U,$J,358.3,27443,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,27443,1,2,0)
;;=2^J2358
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1PV 3751 printed Nov 22, 2024@17:23:39 Page 2
IBDEI1PV ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,27429,1,0)
+2 ;;=^358.31IA^3^2
+3 ;;^UTILITY(U,$J,358.3,27429,1,2,0)
+4 ;;=2^H0020
+5 ;;^UTILITY(U,$J,358.3,27429,1,3,0)
+6 ;;=3^Methadone Administration &/or Svc by Lincensed Program
+7 ;;^UTILITY(U,$J,358.3,27430,0)
+8 ;;=H0025^^112^1330^2^^^^1
+9 ;;^UTILITY(U,$J,358.3,27430,1,0)
+10 ;;=^358.31IA^3^2
+11 ;;^UTILITY(U,$J,358.3,27430,1,2,0)
+12 ;;=2^H0025
+13 ;;^UTILITY(U,$J,358.3,27430,1,3,0)
+14 ;;=3^Addictions Health Prevention/Education
+15 ;;^UTILITY(U,$J,358.3,27431,0)
+16 ;;=H0030^^112^1330^4^^^^1
+17 ;;^UTILITY(U,$J,358.3,27431,1,0)
+18 ;;=^358.31IA^3^2
+19 ;;^UTILITY(U,$J,358.3,27431,1,2,0)
+20 ;;=2^H0030
+21 ;;^UTILITY(U,$J,358.3,27431,1,3,0)
+22 ;;=3^Addictions Hotline Services
+23 ;;^UTILITY(U,$J,358.3,27432,0)
+24 ;;=T1016^^112^1331^1^^^^1
+25 ;;^UTILITY(U,$J,358.3,27432,1,0)
+26 ;;=^358.31IA^3^2
+27 ;;^UTILITY(U,$J,358.3,27432,1,2,0)
+28 ;;=2^T1016
+29 ;;^UTILITY(U,$J,358.3,27432,1,3,0)
+30 ;;=3^Case Management per 15min
+31 ;;^UTILITY(U,$J,358.3,27433,0)
+32 ;;=96372^^112^1332^1^^^^1
+33 ;;^UTILITY(U,$J,358.3,27433,1,0)
+34 ;;=^358.31IA^3^2
+35 ;;^UTILITY(U,$J,358.3,27433,1,2,0)
+36 ;;=2^96372
+37 ;;^UTILITY(U,$J,358.3,27433,1,3,0)
+38 ;;=3^Ther/Proph/Diag Inj SC/IM
+39 ;;^UTILITY(U,$J,358.3,27434,0)
+40 ;;=96374^^112^1332^2^^^^1
+41 ;;^UTILITY(U,$J,358.3,27434,1,0)
+42 ;;=^358.31IA^3^2
+43 ;;^UTILITY(U,$J,358.3,27434,1,2,0)
+44 ;;=2^96374
+45 ;;^UTILITY(U,$J,358.3,27434,1,3,0)
+46 ;;=3^Ther/Proph/Diag Inj IV Push
+47 ;;^UTILITY(U,$J,358.3,27435,0)
+48 ;;=96376^^112^1332^3^^^^1
+49 ;;^UTILITY(U,$J,358.3,27435,1,0)
+50 ;;=^358.31IA^3^2
+51 ;;^UTILITY(U,$J,358.3,27435,1,2,0)
+52 ;;=2^96376
+53 ;;^UTILITY(U,$J,358.3,27435,1,3,0)
+54 ;;=3^Tx/Pro/Dx Inj,ea addl sequential IVP of Same Drug-Add-on
+55 ;;^UTILITY(U,$J,358.3,27436,0)
+56 ;;=J2680^^112^1333^3^^^^1
+57 ;;^UTILITY(U,$J,358.3,27436,1,0)
+58 ;;=^358.31IA^3^2
+59 ;;^UTILITY(U,$J,358.3,27436,1,2,0)
+60 ;;=2^J2680
+61 ;;^UTILITY(U,$J,358.3,27436,1,3,0)
+62 ;;=3^Fluphenazine Decanoate up to 25mg
+63 ;;^UTILITY(U,$J,358.3,27437,0)
+64 ;;=J1631^^112^1333^4^^^^1
+65 ;;^UTILITY(U,$J,358.3,27437,1,0)
+66 ;;=^358.31IA^3^2
+67 ;;^UTILITY(U,$J,358.3,27437,1,2,0)
+68 ;;=2^J1631
+69 ;;^UTILITY(U,$J,358.3,27437,1,3,0)
+70 ;;=3^Haloperidol Decanoate per 50mg
+71 ;;^UTILITY(U,$J,358.3,27438,0)
+72 ;;=J2315^^112^1333^5^^^^1
+73 ;;^UTILITY(U,$J,358.3,27438,1,0)
+74 ;;=^358.31IA^3^2
+75 ;;^UTILITY(U,$J,358.3,27438,1,2,0)
+76 ;;=2^J2315
+77 ;;^UTILITY(U,$J,358.3,27438,1,3,0)
+78 ;;=3^Naltrexone,Depot Form 1mg
+79 ;;^UTILITY(U,$J,358.3,27439,0)
+80 ;;=J2426^^112^1333^7^^^^1
+81 ;;^UTILITY(U,$J,358.3,27439,1,0)
+82 ;;=^358.31IA^3^2
+83 ;;^UTILITY(U,$J,358.3,27439,1,2,0)
+84 ;;=2^J2426
+85 ;;^UTILITY(U,$J,358.3,27439,1,3,0)
+86 ;;=3^Paliperidone Palmitate Extend Release per 1mg
+87 ;;^UTILITY(U,$J,358.3,27440,0)
+88 ;;=J2794^^112^1333^8^^^^1
+89 ;;^UTILITY(U,$J,358.3,27440,1,0)
+90 ;;=^358.31IA^3^2
+91 ;;^UTILITY(U,$J,358.3,27440,1,2,0)
+92 ;;=2^J2794
+93 ;;^UTILITY(U,$J,358.3,27440,1,3,0)
+94 ;;=3^Risperidone Long Act per 0.5mg
+95 ;;^UTILITY(U,$J,358.3,27441,0)
+96 ;;=J2315^^112^1333^9^^^^1
+97 ;;^UTILITY(U,$J,358.3,27441,1,0)
+98 ;;=^358.31IA^3^2
+99 ;;^UTILITY(U,$J,358.3,27441,1,2,0)
+100 ;;=2^J2315
+101 ;;^UTILITY(U,$J,358.3,27441,1,3,0)
+102 ;;=3^Vivitrol 1mg
+103 ;;^UTILITY(U,$J,358.3,27442,0)
+104 ;;=J0401^^112^1333^1^^^^1
+105 ;;^UTILITY(U,$J,358.3,27442,1,0)
+106 ;;=^358.31IA^3^2
+107 ;;^UTILITY(U,$J,358.3,27442,1,2,0)
+108 ;;=2^J0401
+109 ;;^UTILITY(U,$J,358.3,27442,1,3,0)
+110 ;;=3^Aripiprazole Ext Rel 1mg
+111 ;;^UTILITY(U,$J,358.3,27443,0)
+112 ;;=J2358^^112^1333^6^^^^1
+113 ;;^UTILITY(U,$J,358.3,27443,1,0)
+114 ;;=^358.31IA^3^2
+115 ;;^UTILITY(U,$J,358.3,27443,1,2,0)
+116 ;;=2^J2358
